Drug dapagliflozin has finally received green signal from the Food and Drug Administration (FDA) for its marketing in the US. Dapagliflozin, the second of a new class of medications that aims to improve glycemic control in Type 2 diabetes patients, will be marketed under the name Farxiga. With this development, the new drug will join the prominent diabetes medications, including metformin, … [Read more...]
You are here: Home / Archives for Dapagliflozin